For more information please call:
1.877.CRIVER.1 (1.877.274.8371)askcharlesriver@crl.com
*indicates a required field.
The information you provided will be kept confidential.
oct. 06
Charles River recently launched an innovative new website, LabOfTomorrow.com, designed to provide pharmaceutical manufacturers with a personalized journey through the implementation of rapid endotoxin testing solutions. Set in a virtual biopharmaceutical company, the website enables visitors to compare traditional endotoxin testing processes with the PAT-aligned endotoxin testing solutions utilized in the Lab of Tomorrow. These PAT-aligned endotoxin testing solutions have been designed to improve test turnaround time, ensure regulatory compliance, and develop manufacturing efficiencies. The interactive problem-solving journey is complete with animation and narration to provide an engaging and useful experience. To learn more, visit www.laboftomorrow.com.
sept. 09
WILMINGTON, MA, September 9, 2008 (Business Wire) – Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the acquisition of privately-held NewLab BioQuality AG (NewLab), a Dusseldorf, Germany-based provider of safety and quality control services to biopharmaceutical clients. NewLab joins Charles River Biopharmaceutical Services, which provides services to support the development and manufacture of biologics.
juil. 29
Charles River Laboratories International, Inc. (NYSE: CRL), a leading global provider of research models and associated services and of preclinical drug development services, today announced that it has mutually agreed with WuXi PharmaTech (Cayman) Inc. (NYSE: WX) to terminate their previously announced acquisition agreement. The Company also announced that its Board of Directors has authorized a new $500 million stock repurchase program.
sept. 08–sept. 11
WMIC 2010 will bring attendees from different disciplines together for a comprehensive examination of the role of molecular imaging in biomedical problems. With the addition of MIR Preclinical Services, Piedmont Research Center and Cerebricon, Charles River has further expanded our discovery expertise in the key therapeutic areas of CNS, inflammation, and oncology, all complemented by cutting-edge in vivo imaging capabilities. Visit us in booth #223 to learn how our extensive service portfolio can help you with your most challenging drug development needs.
sept. 13–sept. 15
The Biotech symposium is designed to provide insights into nonclinical development of biologics. Specific topics that will be covered include: Safety Pharmacology of Therapeutic Proteins; Impact of Immunomodulatory Agents on Host Resistance; New Paradigms for Predicting Cancer Risks Posed by Immunosuppressive Drugs; PK/PD Modeling: Extrapolating from Animal Data into First-in-Human Dose; and DART Programs for Biotherapeutics: Study Designs, Challenges and Regulatory Influences. In addition to the symposium, we will offer a workshop on endemic diseases and micro-flora as they relate to toxicology on September 12th.
We are looking for a Pathologist at Charles River Montreal. This position will be responsible for overseeing necropsy, perfoming histopathological examinations, authoring pathology reports, providing pathology expertise to multidisciplinary teams, and communicating results with sponsors.
This position is responsible for providing oversight, technical support and guidance to ensure that the company’s financial statements and records are prepared in accordance with company policy and Generally Accepted Accounting Principles; managing the global company consolidation on a monthly basis; ensuring corporate consolidation reconciliations are properly completed, reviewed and documented; gathering and reviewing monthly, quarterly and annual information for external reporting, audits, reviews and tax compliance; preparing and/or reviewing monthly income statement and balance sheet analysis for specific corporate and total company accounts; documenting and testing existing internal controls in support of Sarbanes-Oxley Section 404.
This position is responsible for leading the design, development, and implementation of web-based systems, such as intranet, internet, and customer portal/extranet, to support business and scientific functions throughout the Charles River group.
This position is responsible for supporting the tax function by researching, analyzing, recommending and implementing a variety of tax strategies; coordinating the timely and accurate filing of income tax returns, maintaining tax records and related schedules and reports; preparing and collecting data necessary for local, state and federal tax returns; and preparing reports and schedules regarding tax or treasury issues as required.
Charles River Laboratories, Inc.